Metastatic or Locally Advanced NSCLC
1 clinical trials · Condition
◉ Watch Metastatic or Locally Advanced NSCLC
| Record | Firm | Date |
|---|---|---|
| Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy (NCT05000710) | Sheba Medical Center | 2021-12-09 |
Track Metastatic or Locally Advanced NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.